FDA Inspection 1181508 — Endonovo Therapeutics, Inc.
The FDA completed an inspection of Endonovo Therapeutics, Inc. on Oct 13, 2022 in Woodland Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 13, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Woodland Hills, CA (United States)